USD/JPY bulls looking to extend the momentum beyond 50-day SMA
|- USD/JPY continued scaling higher through the mid-European session on Tuesday.
- Encouraging data on coronavirus vaccine trials remained supportive of the uptick.
- Sliding US bond yields, broad-based USD weakness might cap any further gains.
The offered tone surrounding the Japanese yen lifted the USD/JPY pair to fresh one-week tops, around the 107.75 region. Bulls might now be looking to extend the momentum further beyond the key 50-day SMA barrier.
The pair added to the overnight modest positive move and gained some follow-through traction for the second straight session on Tuesday. The uptick was being supported by receding demand for the safe-haven Japanese yen amid signs of progress in the search for a COVID-19 vaccine.
The US drugmaker Moderna said on Monday that clinical results suggested its vaccine has a high probability to protect from the deadly coronavirus disease. This comes on the back of the recent optimism over the easing of lockdown restrictions globally and prompted investors to dump traditional safe-haven currencies.
Despite the Fed Chair Jerome Powell's upbeat comments about the US economy, the US dollar struggled to attract any meaningful buying interest, instead retreated further from three-week tops set last Friday. This coupled with a modest pullback in the US Treasury bond yields might further contribute towards capping any meaningful positive move for the USD/JPY pair.
Moving ahead, market participants now look forward to the release of the US housing market data – Building Permits and Housing Starts. This will be followed by the Fed Chair Jerome Powell and the US Treasury Secretary Steven Mnuchin's congressional testimony, which might produce some meaningful trading opportunities during the early North American session.
Technical levels to watch
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.